83 related articles for article (PubMed ID: 9481239)
1. A Multiple Sclerosis (MS) Center Injection Training Program.
Pfohl DC
Axone; 1997 Dec; 19(2):29-33. PubMed ID: 9481239
[TBL] [Abstract][Full Text] [Related]
2. Management strategies for improving the tolerability of interferons in the treatment of multiple sclerosis.
Girouard N; Théorêt G
Can J Neurosci Nurs; 2008; 30(4):18-25. PubMed ID: 19146204
[TBL] [Abstract][Full Text] [Related]
3. Self-injection anxiety training: a treatment for patients unable to self-inject injectable medications.
Mohr DC; Cox D; Merluzzi N
Mult Scler; 2005 Apr; 11(2):182-5. PubMed ID: 15794392
[TBL] [Abstract][Full Text] [Related]
4. [Multiple sclerosis: immunomodulators, education, and self-injection].
Moinot N; Anne O; Devoize JL; Artaut-Uriot MS; Aubert-Cetou I; Boissonnot L; Debras C; Lebras F; Loll PY; Godeneche G; Mesnage V; Neau JP;
Rev Neurol (Paris); 2007 Dec; 163(12):1209-13. PubMed ID: 18355468
[TBL] [Abstract][Full Text] [Related]
5. Addressing the need for increased adherence to multiple sclerosis therapy: can delivery technology enhance patient motivation?
Lugaresi A
Expert Opin Drug Deliv; 2009 Sep; 6(9):995-1002. PubMed ID: 19637982
[TBL] [Abstract][Full Text] [Related]
6. Safety and tolerability in relapsing-remitting multiple sclerosis patients treated with high-dose subcutaneous interferon-beta by Rebiject autoinjection over a 1-year period: the CoSa study.
Lugaresi A; Durastanti V; Gasperini C; Lai M; Pozzilli C; Orefice G; Sotgiu S; Pucci E; Ardito B; Millefiorini E;
Clin Neuropharmacol; 2008; 31(3):167-72. PubMed ID: 18520983
[TBL] [Abstract][Full Text] [Related]
7. [The analysis of physicians' work: announcing the end of attempts at in vitro fertilization].
Santiago-Delefosse M; Cahen F; Coeffin-Driol C
Encephale; 2003; 29(4 Pt 1):293-305. PubMed ID: 14615699
[TBL] [Abstract][Full Text] [Related]
8. [Nursing service for MS patients].
Krankenpfl J; 2005; 43(7-10):235. PubMed ID: 16518890
[No Abstract] [Full Text] [Related]
9. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
Sneed RC; May WL; Stencel C
Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
[TBL] [Abstract][Full Text] [Related]
10. [Home exercise therapy in chronic congestive heart failure: observational study of factors affecting adherence to the program].
Capomolla S; Ceresa M; Civardi A; Lupo A; Ventura A; Scabini M; Leonelli P; Salvaneschi G; Petocchi A; Pinna G; Ferrari M; Febo O; Caporotondi A; Guazzotti G; La Rovere MT; Gnemmi M; Maestri R; Cobelli F
Ital Heart J Suppl; 2002 Nov; 3(11):1098-105. PubMed ID: 12506511
[TBL] [Abstract][Full Text] [Related]
11. Treatment of early onset multiple sclerosis with suboptimal dose of interferon beta-1a.
Pakdaman H; Fallah A; Sahraian MA; Pakdaman R; Meysamie A
Neuropediatrics; 2006 Aug; 37(4):257-60. PubMed ID: 17177154
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a MS specialist nurse programme.
Forbes A; While A; Mathes L; Griffiths P
Int J Nurs Stud; 2006 Nov; 43(8):985-1000. PubMed ID: 16412443
[TBL] [Abstract][Full Text] [Related]
13. An evaluation of children's metered-dose inhaler technique for asthma medications.
Burkhart PV; Rayens MK; Bowman RK
Nurs Clin North Am; 2005 Mar; 40(1):167-82. PubMed ID: 15733954
[TBL] [Abstract][Full Text] [Related]
14. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
Wissel J; Entner T
Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
[TBL] [Abstract][Full Text] [Related]
15. A novel needle for subcutaneous injection of interferon beta-1a: effect on pain in volunteers and satisfaction in patients with multiple sclerosis.
Jaber A; Bozzato GB; Vedrine L; Prais WA; Berube J; Laurent PE
BMC Neurol; 2008 Oct; 8():38. PubMed ID: 18845005
[TBL] [Abstract][Full Text] [Related]
16. Panniculitis after subcutaneous injection of interferon beta in a multiple sclerosis patient.
Heinzerling L; Dummer R; Burg G; Schmid-Grendelmeier P
Eur J Dermatol; 2002; 12(2):194-7. PubMed ID: 11872423
[TBL] [Abstract][Full Text] [Related]
17. [The nurse's role in multiple sclerosis treatment adherence].
Morillas-Merienne MJ; Karine P; Prouteau P; Vrillet I
Soins; 2006 Oct; (709):24-9. PubMed ID: 17111862
[No Abstract] [Full Text] [Related]
18. Full results of the Evidence of Interferon Dose-Response-European North American Comparative Efficacy (EVIDENCE) study: a multicenter, randomized, assessor-blinded comparison of low-dose weekly versus high-dose, high-frequency interferon beta-1a for relapsing multiple sclerosis.
Schwid SR; Panitch HS
Clin Ther; 2007 Sep; 29(9):2031-48. PubMed ID: 18035202
[TBL] [Abstract][Full Text] [Related]
19. Neuropharmacology and mental health nurse prescribers.
Skingsley D; Bradley EJ; Nolan P
J Clin Nurs; 2006 Aug; 15(8):989-97. PubMed ID: 16879543
[TBL] [Abstract][Full Text] [Related]
20. [Implementation and assessment of an HIV treatment training program (2000-2001) for patients in Casablanca (Morocco)].
Marchand C; Himmich H; Maaroufi A; Sohier N; Chambon JF; Gagnayre R
Sante; 2005; 15(2):73-80. PubMed ID: 16061443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
